business
Morgan Stanley Maintains an “Equal Weight” Rating on Genmab A/S (GMAB)
Morgan Stanley Maintains an “Equal Weight” Rating on Genmab A/S (GMAB)
Read full story on Yahoo Finance → More top storiesAlso covered by
Investing.com
Morgan Stanley upgrades Assurant stock rating on growth outlook
Investing.com
Morgan Stanley upgrades Orsted stock rating on lower US project risk
Bloomberg Markets
Morgan Stanley Hikes S&P 500 Target to 8,300 on Earnings Boom
Investing.com
UBS maintains Walmart stock Buy rating ahead of earnings print
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop